The Vanguard Group Discloses Position in Life Science REIT plc

The Vanguard Group, Inc. has made a public disclosure regarding its positions in Life Science REIT plc under the Form 8.3 of the Takeover Code. As of April 8, 2026, Vanguard holds an interest of 3,275,054 shares, representing 0.94% of the ordinary shares issued by the firm. The document also mentions The British Land Company plc as another entity involved in disclosures.

The transactions include the sale of 9,898 ordinary shares at a price of 0.41 GBP per unit. No cash-settled or stock-settled derivative transactions have been reported. Furthermore, there are no indemnities, agreements, or understandings relating to options or derivatives surrounding the disclosed securities.

The disclosure follows standard regulations under the Takeover Code, ensuring transparency in the dealings of relevant securities of the mentioned companies.